Brief: Pacira Biosciences Sees Double-Digit Compounded Annual Growth Rate In Product Revenue By 2030
Jan 10 (Reuters) - Pacira Biosciences Inc PCRX.O :
* PACIRA BIOSCIENCES: SEES DOUBLE-DIGIT COMPOUNDED ANNUAL
GROWTH
RATE IN PRODUCT REVENUE BY 2030
* PACIRA BIOSCIENCES INC: SEES 5 PERCENT POINT GROSS MARGIN
IMPROVEMENT OVER 2024 IN PROFITABILITY BY 2030
* PACIRA BIOSCIENCES: PRELIM Q4 EXPAREL NET PRODUCT SALES OF
$147.7 MILLION
Source text: urn:newsml:reuters.com:*:nGNX99rV9F
Further company coverage: PCRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pacira BioSciences
See all newsUS STOCKS ON THE MOVE-Palantir, Haemonetics
U.S. STOCKS ON THE MOVE-Palantir, Haemonetics, Starbucks
Pacira BioSciences jumps on $1.65 billion Viatris buyout deal
Brief: Viatris - Pacira To Pay Viatris $62 Million Termination Fee Under Specified Circumstances
Pacira BioSciences jumps on $1.65 billion Viatris buyout deal